Trogenix

News

Edinburgh-based Trogenix has raised £70m to fund clinical trials of its triple-acting immunotherapies for brain and colorectal cancers.

News

Novartis saw sales grow 3% in the second quarter, returning to growth after a 1% fall in the first quarter caused by generic competition to Entresto.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.